
GeneDx Names Everett Cunningham Its Next Chief Executive
GeneDx has appointed Everett Cunningham as its next chief executive officer, succeeding Katherine Stueland after her five-and-a-half-year tenure. The GeneDx CEO appointment is expected to take effect on or before December 15. Cunningham, who most recently served as president and CEO of Quanterix, will also join the company’s board of directors. Stueland will remain as an adviser through January 31, 2027. Key Takeaways GeneDx appointed Everett Cunningham as its next CEO and a member of






















